About: First-line bevacizumab combined with reduced dose interferon-2a is active in patients with metastatic renal cell carcinoma

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: First-line bevacizumab combined with reduced dose interferon-2a is active in patients with metastatic renal cell carcinoma Goto Sponge Distinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	skos:Concept http://linked.opendata.cz/ontology/domain/vavai/Vysledek
Description	This retrospoective subgroup analysis suggests that the dose od IFN can be reduced to manager side-effects while maintaining efficacy in patiens with mrcci recweiving bevacizumat + IFN This retrospoective subgroup analysis suggests that the dose od IFN can be reduced to manager side-effects while maintaining efficacy in patiens with mrcci recweiving bevacizumat + IFN (en) Popsán efekt redukce dávky interferonu na účinnost v kombinaci s bevacizumabem u karcinomu ledviny (cs)
Title	First-line bevacizumab combined with reduced dose interferon-2a is active in patients with metastatic renal cell carcinoma První linie bevacizumabu v kombinaci s redukovanou dávkou interferonu-α2a je aktivní u pacientů s karcinomem ledviny (cs) First-line bevacizumab combined with reduced dose interferon-2a is active in patients with metastatic renal cell carcinoma (en)
skos:prefLabel	First-line bevacizumab combined with reduced dose interferon-2a is active in patients with metastatic renal cell carcinoma První linie bevacizumabu v kombinaci s redukovanou dávkou interferonu-α2a je aktivní u pacientů s karcinomem ledviny (cs) First-line bevacizumab combined with reduced dose interferon-2a is active in patients with metastatic renal cell carcinoma (en)
skos:notation	RIV/61989592:15110/08:00007569!RIV09-MSM-15110___
http://linked.open...avai/riv/aktivita	S
http://linked.open...avai/riv/aktivity	S
http://linked.open...iv/cisloPeriodika	8
http://linked.open...vai/riv/dodaniDat	2009
http://linked.open...aciTvurceVysledku	Melichar, Bohuslav
http://linked.open.../riv/druhVysledku	J - Článek v odborném periodiku
http://linked.open...iv/duvernostUdaju	S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open...titaPredkladatele	Univerzita Palackého v Olomouci / Lékařská fakulta
http://linked.open...dnocenehoVysledku	368120
http://linked.open...ai/riv/idVysledku	RIV/61989592:15110/08:00007569
http://linked.open...riv/jazykVysledku	eng - angličtina
http://linked.open.../riv/klicovaSlova	Antiangiogenic therapy; bevacizumab; interferon-α; renal cell carcinoma; vascular endothelial growth (en)
http://linked.open.../riv/klicoveSlovo	bevacizumab interferon-α renal cell carcinoma Antiangiogenic therapy vascular endothelial growth
http://linked.open...odStatuVydavatele	GB - Spojené království Velké Británie a Severního Irska
http://linked.open...ontrolniKodProRIV	[A5E5CE69CBC8]
http://linked.open...i/riv/nazevZdroje	Annals of Oncology
http://linked.open...in/vavai/riv/obor	FD
http://linked.open...ichTvurcuVysledku	1 (xsd:int)
http://linked.open...cetTvurcuVysledku	6 (xsd:int)
http://linked.open...UplatneniVysledku	2008
http://linked.open...v/svazekPeriodika	19
http://linked.open...iv/tvurceVysledku	Melichar, Bohuslav Bracarda, S. Koralewski, P. Pluzanska, A. Revaud, A. Szczyylik, C.
issn	0923-7534
number of pages	7 (xsd:int)
http://localhost/t...ganizacniJednotka	15110
is http://linked.open...avai/riv/vysledek of	First-line bevacizumab combined with reduced dose interferon-2a is active in patients with metastatic renal cell carcinoma First-line bevacizumab combined with reduced dose interferon-2a is active in patients with metastatic renal cell carcinoma First-line bevacizumab combined with reduced dose interferon-2a is active in patients with metastatic renal cell carcinoma First-line bevacizumab combined with reduced dose interferon-2a is active in patients with metastatic renal cell carcinoma

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 112 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software